Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Conflict of Interest
Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.
Should you be removed from our database? Contact us at [email protected]. Read more below.
Julia Ljubimova
Cedars Sinai Medical Center, Department: Na
Should you be removed from our database? Contact us at [email protected]. Read more below.
Arrogene, Inc.
Equity Interest - Non-publicly traded entity ( e.g., stock, stock option, or other ownership interest)
Please see attached management plan.
Glial tumor image-guided surgery and treatment
PROJECT NARRATIVE In spite of huge scientific and clinical effort, and a wealth of new data on glioma biology, the patients? survival did not significantly change in the last 25 years. Resection of the tumor bulk has been the major clinically successful course in the treatment of glioblastoma, however, gliomas are not completely separable from the normal brain due to deep infiltration of tumor cells into normal brain parenchyma thus, it is important to develop new imaging and drug delivery technologies for effective glioma targeting to specifically image cancer cells and effectively treat after. Our proposal focusing on this unmet clinical need fully fits the NIH FOA PAR-13-185 ?The innovating research in image-guided drug delivery (IGDD) for cancer and other diseases?.
Filed on August 02, 2016.
Tell us what you know about Julia Ljubimova's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “Julia Ljubimova”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| Julia Ljubimova | Cedars Sinai Medical Center | Conflict of Interest | Arrogene, Inc. | Value cannot be readily determined |
| Julia Ljubimova | Cedars Sinai Medical Center | Conflict of Interest | Arrogene, Inc. | $20,000 - $39,999 |
| Julia Ljubimova | Cedars Sinai Medical Center | Conflict of Interest | Arrogene, Inc. | Value cannot be readily determined |
| Julia Ljubimova | Cedars Sinai Medical Center | Conflict of Interest | Arrogene, Inc. | Value cannot be readily determined |
| Julia Ljubimova | Cedars Sinai Medical Center | Conflict of Interest | Arrogene, Inc. | $20,000 - $39,999 |
| Julia Ljubimova | Cedars Sinai Medical Center | Conflict of Interest | Arrogene, Inc. | Value cannot be readily determined |
| Julia Ljubimova | Cedars Sinai Medical Center | Conflict of Interest | Arrogene, Inc. | $20,000 - $39,999 |
| Julia Ljubimova | Cedars Sinai Medical Center | Conflict of Interest | Arrogene, Inc. | $20,000 - $39,999 |
| Julia Ljubimova | Cedars Sinai Medical Center | Conflict of Interest | Arrogene, Inc. | $20,000 - $39,999 |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.